ARTICLE | Clinical News
HaMPCs: Phase 0 started
September 29, 2014 7:00 AM UTC
Cellular Biomedicine began a 12-month single-blind, Chinese Phase 0 trial to evaluate HaMPCs in combination with lavage, debridement and/or microfracture in about 30 patients with cartilage defects fr...